| 000 | 01700 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515045855.0 | ||
| 264 | 0 | _c20070426 | |
| 008 | 200704s 0 0 eng d | ||
| 022 | _a0889-1591 | ||
| 024 | 7 |
_a10.1016/j.bbi.2006.10.001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGalin, F Shawn | |
| 245 | 0 | 0 |
_aPossible therapeutic vaccines for canine myasthenia gravis: implications for the human disease and associated fatigue. _h[electronic resource] |
| 260 |
_bBrain, behavior, and immunity _cMar 2007 |
||
| 300 |
_a323-31 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Evaluation Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibody Formation _ximmunology |
| 650 | 0 | 4 |
_aAutoantibodies _ximmunology |
| 650 | 0 | 4 |
_aB-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aDog Diseases _xdrug therapy |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 |
_aFatigue _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMyasthenia Gravis _xcomplications |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aReceptors, Cholinergic _ximmunology |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVaccines _ximmunology |
| 700 | 1 | _aChrisman, Cheryl L | |
| 700 | 1 | _aCook, James R | |
| 700 | 1 | _aXu, Likang | |
| 700 | 1 | _aJackson, Patricia L | |
| 700 | 1 | _aNoerager, Brett D | |
| 700 | 1 | _aWeathington, Nathaniel M | |
| 700 | 1 | _aBlalock, J Edwin | |
| 773 | 0 |
_tBrain, behavior, and immunity _gvol. 21 _gno. 3 _gp. 323-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bbi.2006.10.001 _zAvailable from publisher's website |
| 999 |
_c16685552 _d16685552 |
||